Recent news on Dexmedetomidine

Abbott pulls out of developing Orion's Simdax in the USA  -  Apr 26, 2007
Pharma Times (subscription),A Phase III study looking at Precedex (dexmedetomidine) as a long-term infusion for the sedation of patients in intensive care is also underway,

Abbott pulls out of developing Orion's Simdax in the USA  -  26 Apr 2007
Pharma Times (subscription),A Phase III study looking at Precedex (dexmedetomidine) as a long-term infusion for the sedation of patients in intensive care is also underway,

ORION: Orion Group Interim Report 1-3/2007  -  Apr 25, 2007
Kauppalehti (press release),The clinical Phase 3 is being started in May with dexmedetomidine (Precedex®) as a long-term infusion for the sedation of patients in intensive care,

Orion Oyj: Bulletin of orion corporation financial statements for ...  -  Feb 6, 2007
Kauppalehti (press release),The clinical Phase 3 is being started with dexmedetomidine (Precedex®) as a long-term infusion for the sedation of patients in intensive care,

Portion of Orion profits may go towards new Simdax study  -  Feb 7, 2007
Pharma Times (subscription),A Phase III study looking at Precedex (dexmedetomidine) as a long-term infusion for the sedation of patients in intensive care is also underway.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional